242 related articles for article (PubMed ID: 36638937)
1. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche.
Xia C; Bai W; Deng T; Li T; Zhang L; Lu Z; Zhang Z; Li M; He Q
Acta Biomater; 2023 Mar; 158():708-724. PubMed ID: 36638937
[TBL] [Abstract][Full Text] [Related]
2. Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells.
Long Y; Lu Z; Xu S; Li M; Wang X; Zhang Z; He Q
Nano Lett; 2020 Apr; 20(4):2219-2229. PubMed ID: 31823615
[TBL] [Abstract][Full Text] [Related]
3. Micellar nanoparticles inhibit the postoperative inflammation, recurrence and pulmonary metastasis of 4T1 breast cancer by blocking NF-κB pathway and promoting MDSCs depletion.
Lu Z; Ma L; Mei L; Ren K; Li M; Zhang L; Liu X; He Q
Int J Pharm; 2022 Nov; 628():122303. PubMed ID: 36265660
[TBL] [Abstract][Full Text] [Related]
4. Micellar nanoparticles inhibit breast cancer and pulmonary metastasis by modulating the recruitment and depletion of myeloid-derived suppressor cells.
Lu Z; Liu H; Ma L; Ren K; He Z; Li M; He Q
Nanoscale; 2022 Dec; 14(46):17315-17330. PubMed ID: 36374496
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
[TBL] [Abstract][Full Text] [Related]
6. MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation.
Wang Y; Ding Y; Guo N; Wang S
Front Immunol; 2019; 10():172. PubMed ID: 30792719
[TBL] [Abstract][Full Text] [Related]
7. ROS-responsive core-shell nano-inhibitor impedes pyruvate metabolism for reinforced photodynamic therapy and interrupted pre-metastatic niche formation.
Lv M; Zhao B; Zhang J; Miao G; Wei S; Tang Y; Liu X; Qian H; Huang D; Chen W; Zhong Y
Acta Biomater; 2024 Jul; 182():288-300. PubMed ID: 38729547
[TBL] [Abstract][Full Text] [Related]
8. Xiaoliu Pingyi Pecipe Inhibits Lung Pre-Metastatic Niche Formation and Prevents Myeloid-Derived Suppressor Cells Recruitment.
Li H; Yang F; Zhang L; Zhao R; Li X; Li H
Integr Cancer Ther; 2023; 22():15347354231187000. PubMed ID: 37431869
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy.
Xia C; Li M; Ran G; Wang X; Lu Z; Li T; Tang X; Zhang Z; He Q
J Control Release; 2021 Jul; 335():557-574. PubMed ID: 34051289
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer.
Kajihara N; Kobayashi T; Otsuka R; Nio-Kobayashi J; Oshino T; Takahashi M; Imanishi S; Hashimoto A; Wada H; Seino KI
Cancer Immunol Immunother; 2023 Apr; 72(4):851-864. PubMed ID: 36104597
[TBL] [Abstract][Full Text] [Related]
11. Chronic psychological stress promotes breast cancer pre-metastatic niche formation by mobilizing splenic MDSCs via TAM/CXCL1 signaling.
Zheng Y; Wang N; Wang S; Zhang J; Yang B; Wang Z
J Exp Clin Cancer Res; 2023 May; 42(1):129. PubMed ID: 37210553
[TBL] [Abstract][Full Text] [Related]
12. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
[TBL] [Abstract][Full Text] [Related]
14. Lung resided monocytic myeloid-derived suppressor cells contribute to premetastatic niche formation by enhancing MMP-9 expression.
Zhang J; Han X; Shi H; Gao Y; Qiao X; Li H; Wei M; Zeng X
Mol Cell Probes; 2020 Apr; 50():101498. PubMed ID: 31891749
[TBL] [Abstract][Full Text] [Related]
15. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
16. MDSCs: The Key Players in the Formation of Pre-Metastatic Niche.
Cui W; Wang Z; Lv J; Qin Y; Shi H
Front Biosci (Landmark Ed); 2023 Mar; 28(3):58. PubMed ID: 37005751
[TBL] [Abstract][Full Text] [Related]
17. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
18. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
19. [Roles of Myeloid-derived Suppressor Cells in Breast Cancer Metastasis].
Peng XY; Li Y; Xu ZL; Guo Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Jun; 43(3):445-451. PubMed ID: 34238422
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer.
Monteran L; Ershaid N; Doron H; Zait Y; Scharff Y; Ben-Yosef S; Avivi C; Barshack I; Sonnenblick A; Erez N
Nat Commun; 2022 Oct; 13(1):5797. PubMed ID: 36184683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
